title: Fondaparinux as an alternative anticoagulant therapy during pregnancy.
authors.forename: H M
authors.initials: HM
authors.lastname: Knol
authors.forename: L
authors.initials: L
authors.lastname: Schultinge
authors.forename: J J H M
authors.initials: JJ
authors.lastname: Erwich
authors.forename: K
authors.initials: K
authors.lastname: Meijer
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D015331:Cohort Studies; D005260:Female; D000077425:Fondaparinux; D006801:Humans; D018811:Maternal Exposure; D011134:Polysaccharides / Q000627:therapeutic use*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011261:Pregnancy Trimester, First; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D011134:Polysaccharides; D000077425:Fondaparinux